Stockscreener 앱 받기
1.1068
6.12%
-0.0722
Barinthus Biotherapeutics Plc Adr 주식(BRNS)의 최신 뉴스
37,450 Shares in Barinthus Biotherapeutics PLC Sponsored ADR $BRNS Acquired by HighTower Advisors LLC - Defense World
Raymond James Financial Inc. Raises Stock Position in Virtus Terranova U.S. Quality Momentum ETF $JOET - Defense World
Freehold Royalties (TSE:FRU) Stock Price Crosses Above Two Hundred Day Moving Average – What’s Next? - Defense World
Martinrea International (TSE:MRE) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
PNC Financial Services Group Inc. Increases Stake in United Microelectronics Corporation (NYSE:UMC) - Defense World
BRNS’s Market Whiplash: 50.99% YTD Rise, 152.41% Rise in 30 Days - investchronicle.com
BRNS stock touches 52-week low at $0.8 amid market volatility - Investing.com
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why - Nasdaq
Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com
The big rebrand: Why these 4 biopharmas changed their name this year - PharmaVoice
Mexico Shingles Vaccine Market Size & Outlook, 2023-2030 - Grand View Research
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Investing.com UK
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat
0.50%
0.44%
자본화:
|
볼륨(24시간):